The EORTC hyperfractionation trial

Editorial

H R Withers. Radiother Oncol. 1992 Dec.

. 1992 Dec;25(4):229-30.

doi: 10.1016/0167-8140(92)90241-l.

No abstract available

Comment on

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy.
Horiot JC, Le Fur R, N'Guyen T, Chenal C, Schraub S, Alfonsi S, Gardani G, Van Den Bogaert W, Danczak S, Bolla M, et al. Horiot JC, et al. Radiother Oncol. 1992 Dec;25(4):231-41. doi: 10.1016/0167-8140(92)90242-m. Radiother Oncol. 1992. PMID: 1480768 Clinical Trial.

Is hyperfractionation really better?
Rudoltz MS, Mohiuddin M. Rudoltz MS, et al. Radiother Oncol. 1993 Dec;29(3):354-5. doi: 10.1016/0167-8140(93)90157-4. Radiother Oncol. 1993. PMID: 8127989 No abstract available.
[Metronidazole in the radiotherapy of malignant neoplasms].
Dar'ialova SL, Poliakov PIu, Kiseleva ES, Zimina ES, Zel'vin BM. Dar'ialova SL, et al. Med Radiol (Mosk). 1986 Jul;31(7):6-13. Med Radiol (Mosk). 1986. PMID: 3526077 Clinical Trial. Russian. No abstract available.
Split-course accelerated hyperfractionation radiotherapy for advanced head and neck cancer: influence of split time and overall treatment time on local control.
Akimoto T, Mitsuhashi N, Hayakawa K, Sakurai H, Murata O, Ishizeki K, Ishikawa H, Nasu S, Yamakawa M, Niibe H. Akimoto T, et al. Jpn J Clin Oncol. 1997 Aug;27(4):240-3. doi: 10.1093/jjco/27.4.240. Jpn J Clin Oncol. 1997. PMID: 9379511
Clinical themoradiotherapy.
Bicher HI, Sandhu TS, Hetzel FW. Bicher HI, et al. Henry Ford Hosp Med J. 1981;29(1):10-5. Henry Ford Hosp Med J. 1981. PMID: 7024208 Review. No abstract available.
Radiotherapy in rectal cancer.
Glimelius B. Glimelius B. Br Med Bull. 2002;64:141-57. doi: 10.1093/bmb/64.1.141. Br Med Bull. 2002. PMID: 12421731 Review.